a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors
Industry Biotechnology
A.I.dvisor indicates that over the last year, PSTX has been loosely correlated with NTLA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PSTX jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To PSTX | 1D Price Change % | ||
---|---|---|---|---|
PSTX | 100% | -11.11% | ||
NTLA - PSTX | 49% Loosely correlated | -3.24% | ||
ALEC - PSTX | 47% Loosely correlated | -7.66% | ||
EDIT - PSTX | 46% Loosely correlated | -3.58% | ||
INZY - PSTX | 42% Loosely correlated | -5.59% | ||
CRSP - PSTX | 41% Loosely correlated | -1.85% | ||
More |
Ticker / NAME | Correlation To PSTX | 1D Price Change % |
---|---|---|
PSTX | 100% | -11.11% |
solid tumors theme (2 stocks) | 78% Closely correlated | -3.35% |
biopharmaceutical theme (10 stocks) | 46% Loosely correlated | -2.76% |
treatment theme (56 stocks) | 35% Loosely correlated | -1.12% |
therapeutics theme (53 stocks) | 32% Poorly correlated | -2.44% |